Prosight Management Adds $42.7 Million in Shares of Genomics Firm GeneDx
On May 15, 2026, Prosight Management disclosed a purchase of 468,463 shares of GeneDx Holdings (NASDAQ:WGS), valued at approximately $42.7 million based on quarterly average pricing. The investment increased the firm's position in GeneDx to about 5.51% of its reportable assets under management.
Tickers: $WGS
Topics: genomics portfolio_change stock_purchase